Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Association of Ellipsoid Zone Integrity Features with Visual Acuity in Dry Age-Related Macular Degeneration.
Author Affiliations & Notes
  • John Mamone
    Cole Eye Institute Research, Cleveland Clinic, Cleveland, Ohio, United States
  • Reem Amine
    Cole Eye Institute Research, Cleveland Clinic, Cleveland, Ohio, United States
  • Bassel Hammoud
    Cole Eye Institute Research, Cleveland Clinic, Cleveland, Ohio, United States
  • Charles Clifton Wykoff
    Retina Consultants of Texas, Houston, Texas, United States
  • Yavuz Cakir
    Cole Eye Institute Research, Cleveland Clinic, Cleveland, Ohio, United States
  • Hasan Cetin
    Cole Eye Institute Research, Cleveland Clinic, Cleveland, Ohio, United States
  • Karen Matar
    Cole Eye Institute Research, Cleveland Clinic, Cleveland, Ohio, United States
  • Gagan Kalra
    Cole Eye Institute Research, Cleveland Clinic, Cleveland, Ohio, United States
  • Sari Yordi
    Cole Eye Institute Research, Cleveland Clinic, Cleveland, Ohio, United States
  • Michelle Bonnay
    Cole Eye Institute Research, Cleveland Clinic, Cleveland, Ohio, United States
  • Jamie Reese
    Cole Eye Institute Research, Cleveland Clinic, Cleveland, Ohio, United States
  • Sunil K Srivastava
    Cole Eye Institute Research, Cleveland Clinic, Cleveland, Ohio, United States
  • Justis P Ehlers
    Cole Eye Institute Research, Cleveland Clinic, Cleveland, Ohio, United States
  • Hannah Yu
    Retina Consultants of Texas, Houston, Texas, United States
  • Footnotes
    Commercial Relationships   John Mamone None; Reem Amine None; Bassel Hammoud None; Charles Wykoff Alimera Sciences, Allegro, Allergan, Alynylam, Apellis, Bayer, Clearside, D.O.R.C., EyePoint, Genentech/Roche, Kodiak, Notal Vision, Novartis, ONL Therapeutics, PolyPhotonix, RecensMedical, Regeneron, Regenxbio, Santen, Code C (Consultant/Contractor), Adverum, Allergan, Apellis, Clearside, EyePoint, Genentech/Roch, Neurotech, Novartis, Opthea, Regeneron, Regenxbio, Samsung, Santen, Code F (Financial Support); Yavuz Cakir None; Hasan Cetin None; Karen Matar None; Gagan Kalra None; Sari Yordi None; Michelle Bonnay None; Jamie Reese None; Sunil Srivastava Bausch and Lomb, Adverum, Novartis, and Regeneron., Code C (Consultant/Contractor), Regeneron, Allergan, and Gilead, Code F (Financial Support), Leica, Code P (Patent); Justis Ehlers Zeiss, Leica/Bioptigen, Alcon, Beyeonics. Allergan, Allegro, Adverum, Regeneron, Roche, Genentech, RegenxBIO, Iveric Bio, Boehringer Ingelheim, Apellis, Novartis, Boehringer Ingelheim, Stealth Biotherapeutics, Perceive Biotherapeutics, Exegenesis, Ophthalytics, Eyepoint, Abbvie, Bayer, BVI, Alexion, Code C (Consultant/Contractor), Regeneron, Genentech, Oxurion/Thrombogenics, Alcon, Aerpio, Allergan, Roche, Iveric Bio, Boehringer Ingelheim, Adverum, Novartis, Zeiss, Stealth Biotherapeutics, Perceive Biotherapeutics, Alexion, Beyeonics, Code F (Financial Support), Bioptigen/Leica, Code P (Patent); Hannah Yu None
  • Footnotes
    Support  P30EY025585(BA-A), Research to Prevent Blindness (RPB) Challenge Grant
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 2317. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      John Mamone, Reem Amine, Bassel Hammoud, Charles Clifton Wykoff, Yavuz Cakir, Hasan Cetin, Karen Matar, Gagan Kalra, Sari Yordi, Michelle Bonnay, Jamie Reese, Sunil K Srivastava, Justis P Ehlers, Hannah Yu; Association of Ellipsoid Zone Integrity Features with Visual Acuity in Dry Age-Related Macular Degeneration.. Invest. Ophthalmol. Vis. Sci. 2024;65(7):2317.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Ellipsoid zone (EZ) integrity has been associated with visual function in multiple retinal conditions. This study aims to evaluate the association between EZ integrity features as measured on SD-OCT with visual acuity (VA) in dry age-related macular degeneration (AMD).

Methods : This IRB-approved retrospective image analysis study evaluated eyes with dry AMD to provide quantitative assessment of EZ integrity features and VA analysis. SD-OCT was performed (Spectralis, Heideiberg; or Cirrus, Zeiss) and exported for analysis. For EZ integrity assessment, a machine learning (ML)-enhanced segmentation platform was utilized to provide panmacular segmentation of the EZ and retinal pigment epithelium (RPE) bands. Following initial automated segmentation, a certified reader reviewed every B-scan for segmentation accuracy and corrected any segmentation errors. Measures of EZ integrity included partial and total EZ attenuation burden, indicated by the percentage of the macular cube with EZ-RPE thickness ≤ 20 μm and EZ-RPE= 0 μm, respectively, and EZ-RPE central subfield thickness (CST), i.e. central 1 mm. These measurements were compared in eyes with excellent VA (≥ 20/25 Snellen) and eyes with limited VA (≤20/40 Snellen). In addition, an analysis was performed based on evaluating the mean VA in eyes with total loss of EZ in the CST (i.e, =0 μm), partial loss (i.e., >0 and ≤20 μm) and EZ preservation (i.e,>20 μm).

Results : This analysis included 395 eyes of 395 patients. In the first assessment, subjects with excellent VA showed lower baseline partial and total EZ attenuation (n= 368, mean= 4.51% and 1.37%, respectively) than subjects that had limited VA (n=635, mean= 28.26% and 17.98%, respectively). In addition, baseline EZ-RPE CST was greater in eyes that had excellent VA (mean= 32.1µm) than eyes that had limited VA (mean= 12.0µm). When evaluated based on EZ parameters, the mean VA with total EZ loss in the CST was 20/200, with partial EZ attenuation in the CST was 20/70, and with EZ preserivation of the CST the mean VA was 20/30. The results in both assessments were highly statistically significant (All p-values<10^-60).

Conclusions : This report reinforces the critical link between EZ integrity and VA in dry AMD, reflecting its functional role in dry AMD patients and supporting the use of EZ integrity as a key endpoint for therapeutic development.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×